(Q34244232)

31 July 2017

title

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada (English)

1 reference

cost-effectiveness analysis

31 July 2017

0 references

1 reference

Stephanie R Earnshaw

1

1 reference

31 July 2017

Cheryl L McDade

2

1 reference

31 July 2017

Giovanni Zanotti

3

1 reference

31 July 2017

Raymond A Farkouh

4

1 reference

31 July 2017

David Strutton

5

1 reference

31 July 2017

publication date

24 April 2012

1 reference

31 July 2017

published in

BMC Infectious Diseases

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

page(s)

101

1 reference

Creative Commons Attribution 2.0 Generic

31 July 2017

copyright license

start time

24 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Invasive bacterial diseases in northern Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Epidemiological and economic burden of pneumococcal diseases in Canadian children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Progress in the prevention of pneumococcal infection.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae-associated disease following vaccination with PCV-7: a multicountry analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Impact of the pneumococcal conjugate vaccine on otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Cost-effectiveness analysis of pneumococcal vaccination in Spain

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3532329

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINE IN GREATER VANCOUVER, CANADA: 2004???2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-101

Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines

21 January 2018

1 reference

12 December 2020

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults

1 reference

12 December 2020

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006

1 reference

12 December 2020

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine

1 reference

12 December 2020

Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers

1 reference

12 December 2020

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

1 reference

12 December 2020

Response to "Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries"

1 reference

12 December 2020

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

1 reference

12 December 2020

Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada

1 reference

12 December 2020

Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage

1 reference

12 December 2020

Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults

1 reference

12 December 2020

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

1 reference

12 December 2020

Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina

1 reference

12 December 2020

Invasive pneumococcal disease in Australia, 2006

1 reference

12 December 2020

Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics

1 reference

12 December 2020

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs

1 reference

12 December 2020

Incidence of invasive pneumococcal disease after introduction of the Universal Infant Immunization Program, British Columbia (2002-2005)

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-12-101

1 reference

Dimensions Publication ID

31 July 2017

1024603263

0 references

Fatcat ID

release_dbay3felcvea7d3kedrza2ala4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dbay3felcvea7d3kedrza2ala4

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3532329

1 reference

31 July 2017

1 reference